Researcher Profiles

Return to member profile

Ping Xie, PhD

Publications since 2011

Moore, C. R. Edwards, S. K. Xie, P. Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms. J Cancer Sci Ther, 7:67-74, . (PMID: 25960828, PMCID: PMC4422099)

Xie, P. Moore, C. R. Swerdel, M. R. Hart, R. P. Transcriptomic profiling of splenic B lymphomas spontaneously developed in B cell-specific TRAF3-deficient mice. Genom Data, 2:386-388, . (PMID: 25419513, PMCID: PMC4236829)

Lalani, A. I. Moore, C. R. Luo, C. Kreider, B. Z. Liu, Y. Morse, H. C. 3rd Xie, P. Myeloid Cell TRAF3 Regulates Immune Responses and Inhibits Inflammation and Tumor Development in Mice. J Immunol, In process, . (PMID: 25422508)

Edwards, S. Baron, J. Moore, C. R. Liu, Y. Perlman, D. H. Hart, R. P. Xie, P. Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes. J Hematol Oncol, In process, . (PMID: 25200342, PMCID: PMC4172902)

Edwards, S. K. Desai, A. Liu, Y. Moore, C. R. Xie, P. Expression and function of a novel isoform of Sox5 in malignant B cells. Leuk Res, 38:393-401, . (PMID: 24418753, PMCID: PMC3947564)

Perkins, D. J. Polumuri, S. K. Pennini, M. E. Lai, W. Xie, P. Vogel, S. N. Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathog, 9:e1003479, . (PMID: 23853595, PMCID: PMC3708851)

Xie, P. TRAF molecules in cell signaling and in human diseases. J Mol Signal, 8:7, . (PMID: 23758787, PMCID: PMC3697994)

Edwards, S. K. Moore, C. R. Liu, Y. Grewal, S. Covey, L. R. Xie, P. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. BMC Cancer, 13:481, . (PMID: 24131623, PMCID: PMC3853153)

Moore, C. R. Liu, Y. Shao, C. Covey, L. R. Morse, H. C. 3rd Xie, P. Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. Leukemia, 26:1122-1127, . (PMID: 22033491, PMCID: PMC3433763)

Xie, P. Poovassery, J. Stunz, L. L. Smith, S. M. Schultz, M. L. Carlin, L. E. Bishop, G. A. Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes. J Leukoc Biol, 90:1149-1157, . (PMID: 21971520, PMCID: PMC3236554)

Xie, P. Kraus, Z. J. Stunz, L. L. Liu, Y. Bishop, G. A. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling. J Immunol, 186:143-155, . (PMID: 21084666, PMCID: PMC3044490)